TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization

Summary

Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely on clinical development planning (CDP) and probability of technical and regulatory success assessment to antic...